- One Injection
- Autologous Solution
- Lasts up to three years
nSTRIDE autologous treatment for osteoarthritis knee pain
Midland Knee Protect Clinic is pleased to offer nSTRIDE, a novel therapy designed to treat pain and slow the progress of cartilage degradation and destruction in the knee.
What is nSTRIDE?
nSTRIDE is a small injection into your knee joint which is designed to alleviate pain and bring balance to your inflamed knee.
- Significantly reduces pain associated with knee OA up to 3 years
- Significantly improves mobility in the knee joint associated with OA
- 70% improvement in knee pain at 3 years following a single injection
How does it work?
 |
 |
 |
 |
| 1 | 2 | 3 | 4 |
| Your surgeon takes some of your blood and harvests the white blood cells from it. | Within 20 minutes your blood is processed to make anti-inflammatory proteins. | Your surgeon injects those proteins back into your joint. | Your pain is reduced, your mobility is increased and your disease progression might slow down. |
Who can have nSTRIDE?
nSTRIDE is suitable for patients with knee pain from osteoarthritis.
If other early intervention therapies and conservative therapies have not worked for you, you may be a candidate for nSTRIDE treatment. Our clinicians can advise on whether nSTRIDE is suitable for you.
References
1. Kon E. et al. (2018): Two-year clinical outcomes of an Autologous Protein Solution injection for knee osteoarthritis. ICRS 14th World Congress.
2. A Multicenter, Double-Blind, Randomized, Placebo [Saline]-Controlled Pilot Study of a Single, Intra-Articular Injection of Autologous Protein Solution in Patients with Osteoarthritis of the Knee.
Clinical Investigation Report – 36 Month, APSS-33-00, Version 1.0. 14. January 2019.†<
† As measured by WOMAC pain scores reported by patients continuing follow-up through 3 years (n = 19). 19 out of the original cohort of 31.